245
Participants
Start Date
June 16, 2014
Primary Completion Date
February 15, 2016
Study Completion Date
April 20, 2016
Romosozumab
Administered by subcutaneous injection once a month.
Placebo
Administered by subcutaneous injection once a month.
Research Site, Ballerup Municipality
Research Site, Leuven
Research Site, Bern
Research Site, Genk
Research Site, Liège
Research Site, Zurich
Research Site, Zurich
Research Site, Ghent
Research Site, Aalborg
Research Site, Bethesda
Research Site, Mexicali
Research Site, Monterrey
Research Site, Culiacán
Research Site, Lakewood
Research Site, Albuquerque
Research Site, Moscow
Research Site, Yaroslavl
Research Site, Saint Petersburg
Research Site, Bogota
Research Site, Medellín
Research Site, Ostrava-Trebovice
Research Site, Pilsen
Research Site, Praha 11 - Chodov
Research Site, Mizunami-shi
Research Site, Yokohama
Research Site, Bungoono-shi
Research Site, Takatsuki-shi
Research Site, Hachioji-shi
Research Site, Shinagawa-ku
Research Site, Toshima-ku
Research Site, Lodz
Research Site, Świdnik
Research Site, Warsaw
Research Site, Wroclaw
Lead Sponsor
Amgen
INDUSTRY